Resources

Novel Coronavirus (COVID-19) Vaccine Development – Wave 3

Given the recent roll-out of the COVID-19 vaccine across the US, InCrowd conducted its third wave of research on perceptions and observations of infectious disease experts on the COVID-19 vaccine to gauge progress and perceptions. This report compares recent findings on efficacy, impact, and recommendations related to the COVID-19 vaccine with data from earlier in the year.*

* Please note, views in this survey reflect opinions only as reported by responding physicians.

Methodology:

  • Method:
    • 10-Minute MicroSurvey via InCrowd
  • Crowds:
    • Infectious disease doctors
  • Sample Size:
    • n = 101
      • Community Hospital, Academic Hospital, Office-based
  • Fielding Period:
    • January 21st – 22nd

InCrowd’s other COVID-19 Tracking Reports:

Please fill out the form below to access this content

Related Resources

IV Fluid Supply Chain Disruptions 

IV Fluid Supply Chain Disruptions 

Discover the Impact of Hurricane Helene on IV Fluid Availability When Hurricane Helene disrupted a key IV fluid manufacturing facility in the southeastern US, healthcare systems felt the ripple effects. InCrowd conducted research to uncover how this shortage has...

read more
Physician Burnout: Knowing Your Audience 

Physician Burnout: Knowing Your Audience 

Physician Engagement in a Time of Accelerated Professional Burnout  As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...

read more
ASH 2023 Post-Event Round-Up 

ASH 2023 Post-Event Round-Up 

Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023  In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and...

read more